类粘蛋白2(ORM2)单克隆抗体

Monoclonal Antibody to Orosomucoid 2 (ORM2)

AGP-B; AGP2; Alpha-1-Acid Glycoprotein Type 2

  • 类粘蛋白2(ORM2)单克隆抗体 产品包装(模拟)
  • 类粘蛋白2(ORM2)单克隆抗体 产品包装(模拟)
  • 类粘蛋白2(ORM2)单克隆抗体 DAB staining on IHC-P; Sample: Human Prostate cancer Tissue; Primary Ab: 30µg/ml Mouse Anti-Human a1AGP Antibody Second Ab: 2µg/mL HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody (Catalog: SAA544Mu19)
  • 类粘蛋白2(ORM2)单克隆抗体 DAB staining on IHC-P;
    Sample: Human Liver Tissue;
    Primary Ab: 30µg/ml Mouse Anti-Human a1AGP Antibody
    Second Ab: 2µg/mL HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
    (Catalog: SAA544Mu19)
  • MAB780Hu22.jpg Western Blot; Sample: Lane1: Human Serum; Lane2: Rat Liver lysate; Lane3: Rat Pancreas lysate; Lane4: Rat Bladder lysate Primary Ab: 3ug/ml Mouse Anti-Human a1AGP Antibody Second Ab: 0.2µg/mL HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody (Catalog: SAA544Mu19)
  • Certificate 通过ISO 9001、ISO 13485质量体系认证

特异性

该抗体是针对ORM2的小鼠单克隆抗体。在免疫组织化学染色和免疫印迹实验中能识别ORM2。

用法

Western blotting: 0.01-3µg/mL;
Immunohistochemistry: 5-30µg/mL;
Optimal working dilutions must be determined by end user.

储存

经常使用则4°C保存。-20°C保存不超过两年。避免反复冻融。

稳定性

热稳定性以损失率显示。损失率是由加速降解试验决定,具体方法如下:在37°C孵育48小时,没有显著的降解或者沉淀产生。保质期内,在适当的条件下存储,损失率低于5%。

赠品

相关产品

编号 适用物种:Homo sapiens (Human,人) 应用(仅供研究使用,不用于临床诊断!)
RPB780Hu01 类粘蛋白2(ORM2)重组蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
CPB780Hu21 类粘蛋白2(ORM2)卵白蛋白偶联物 Immunogen; SDS-PAGE; WB.
PAB780Hu01 类粘蛋白2(ORM2)多克隆抗体 WB; IHC; ICC; IP.
LAB780Hu81 类粘蛋白2(ORM2)多克隆抗体(异硫氰酸荧光素标记) WB; IHC; ICC; IF.
LAB780Hu71 类粘蛋白2(ORM2)多克隆抗体(生物素标记) WB; IHC; ICC.
MAB780Hu22 类粘蛋白2(ORM2)单克隆抗体 WB; IHC
MAB780Hu21 类粘蛋白2(ORM2)单克隆抗体 WB; IHC; ICC; IP.
SEB780Hu 类粘蛋白2(ORM2)检测试剂盒(酶联免疫吸附试验法) Enzyme-linked immunosorbent assay for Antigen Detection.
LMB780Hu 类粘蛋白2(ORM2)等多因子检测试剂盒(流式荧光发光法) FLIA Kit for Antigen Detection.

参考文献

杂志 参考文献
Clin Exp Nephrol Differentially expressed urinary biomarkers in children with idiopathic nephrotic syndrome [PubMed: 26351173]
Free Patents online RHEUMATOID ARTHRITIS RELATED BIOMARKER [20170350884]
Osteoarthritis and Cartilage Orosomucoid 2 serves for predicting but not for monitoring drug response in patients with knee osteoarthritis treated with chondroitin sulfate/glucosamine … [10.1016:j.joca.2018.02.412]
Therapeutic Advances in Chronic Disease Predictive modeling of therapeutic response to chondroitin sulfate/glucosamine hydrochloride in knee osteoarthritis []
Journal of Cosmetic Dermatology Evaluation of serum and urinary orsomucoid protein A in psoriatic patients and their relation to severity of disease [33905172]
留言咨询